Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The expression of CYP24A1 (24-hydroxylase) was significantly increased, which catabolizes both 25(OH)VD 3 and 1,25-hydroxyvitaminD 3
Nanoparticles-based therapeutics for the management of bacterial infections: a special emphasis on FDA approved products and clinical trials
Participants treated with weight-loss drugs regained on average 0.4 kg/month after stopping treatment, regaining, on average, 4.8 kilograms or 10 pounds in the first year
JCL and LAV declare that they have no competing interests that would influence the content of this review
Initial results are often visible within a few days
US$ 20.87
US$ 23.33
US$ 20.61
US$ 28.34
US$ 19.99
US$ 26.83
US$ 25.15
